Phosphorylation of synucleins by members of the Polo-like kinase family.
about
Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of ParkinsonismThe H50Q mutation enhances α-synuclein aggregation, secretion, and toxicityParkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer modelPolo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivoThe benefits of humanized yeast models to study Parkinson's diseasePhosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's diseaseImpaired c-Fos and polo-like kinase 2 induction in the limbic system of fear-conditioned α-synuclein transgenic miceSelective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce α-synuclein phosphorylation in rat brainSynthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational ModificationsThe phosphorylation of α-synuclein: development and implication for the mechanism and therapy of the Parkinson's diseasePhosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactionsAssessing the subcellular dynamics of alpha-synuclein using photoactivation microscopy.Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation.Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.Polo-like kinase 2 activates an antioxidant pathway to promote the survival of cells with mitochondrial dysfunction.The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomerParkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice.Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivoIdentification of the PLK2-dependent phosphopeptidome by quantitative proteomics [corrected].Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathiesCharacterization of kinases involved in the phosphorylation of aggregated α-synuclein.The Interplay between Alpha-Synuclein Clearance and SpreadingInteraction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.Polo-Like Kinase 3 Appears Dispensable for Normal Retinal Development Despite Robust Embryonic Expression.Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra.Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration.Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease.A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's diseaseCharacterization of semisynthetic and naturally Nα-acetylated α-synuclein in vitro and in intact cells: implications for aggregation and cellular properties of α-synuclein.Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73.α-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5/Plk2PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cellsEffects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.Age- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains.Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
P2860
Q21131229-A51E9E62-B8DB-4716-B6B3-2F813312338DQ24299289-05DE0CC5-D090-4B0A-8829-37E58CD7BDC9Q24305472-BB0B0DDF-BEB8-4725-9A84-1AD9660ADE36Q24320103-A6059DC0-04BB-464A-9172-623BCC881E26Q26853041-029D9F1C-5E68-4702-88D1-433D36BA2E61Q27316174-797C04AD-8523-4447-B43F-FA9606CCFA30Q27334377-8629124D-4ECB-4B1C-A134-737BE6C17AB4Q27684872-5A0D69D7-23B6-48C1-A44C-FE918E6179E8Q28081548-31D5789F-D2B5-4DDE-B48A-250696A57F6CQ28087330-BBDF2F13-6F73-4923-85F3-65B5B5727E97Q30496792-2F8AA7D0-146C-496A-9318-5A68732F8C77Q30539260-BD0E6E26-7514-4872-9182-5F80B77C36C0Q33720188-34B8A93A-DB29-4C18-A7C1-A70C871C264AQ33797449-D0D7F7FD-068F-466F-BDD3-081FF372FCA4Q33970870-756CDB32-8132-4AC6-8460-C87DBC3F7268Q33991720-5A47FAB0-4849-4BFF-8DA3-0C8F1DA18251Q34252869-EA3C7185-A495-40C1-BBAA-7086DADFB2B9Q34492912-8FEF9E3B-B154-4600-8F25-5A36C8289A55Q34591096-985C7688-F529-42F3-94ED-82BE027EB0B1Q35035515-231C2BFC-8248-4D8A-977F-5B0DA6BFF287Q35351512-6AB731B6-3A63-4C04-B4FA-EBA3F62929A0Q35358750-49A166BD-8996-4B07-AC48-B90F41573DF5Q35593764-6FFA0A49-9084-4005-8157-2661E6598A6CQ35795019-E8CD7486-5604-4037-A234-C98D03E82D8BQ35833984-72EF42DE-000C-498D-A9A2-A3A13EF4AAEEQ35834043-EDBBD30C-FB1E-45E9-B70C-43ADE5583B01Q35947553-3ED45775-C036-4549-BE05-BA9C616296ABQ36004226-8652E984-B4EC-4385-8539-87733E701BA1Q36040875-DAC361F0-7AEE-4756-A7CD-ED197D553769Q36063269-231823D9-53B7-4395-BD82-A19E250E09FDQ36109452-6D20E222-D8C5-4A08-834A-D5E897D054E6Q36200921-F8BDE4E0-6C10-4E16-9799-AA87DF7484FDQ36217340-6C3AAA96-48F4-4329-85EB-3B3D6042CF48Q36326031-716A3375-DE8A-46F3-9AA9-86A4C0F76CEDQ36342850-91968A0D-38EB-434F-B976-BD1AB6217610Q36451518-B6BFEA95-A44A-4D9C-9909-C3F3D24C73EBQ36744478-344CB0BC-35BA-48C9-AE4B-F6CB66460714Q36887384-41C9D965-F7FF-487F-8037-A2D940B80C41Q36962314-57421919-5F84-4F2A-9863-0EECCD995F5BQ37038032-A613C81F-ABAC-47C7-BAD3-83088B1CB19A
P2860
Phosphorylation of synucleins by members of the Polo-like kinase family.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Phosphorylation of synucleins by members of the Polo-like kinase family.
@ast
Phosphorylation of synucleins by members of the Polo-like kinase family.
@en
Phosphorylation of synucleins by members of the Polo-like kinase family.
@nl
type
label
Phosphorylation of synucleins by members of the Polo-like kinase family.
@ast
Phosphorylation of synucleins by members of the Polo-like kinase family.
@en
Phosphorylation of synucleins by members of the Polo-like kinase family.
@nl
prefLabel
Phosphorylation of synucleins by members of the Polo-like kinase family.
@ast
Phosphorylation of synucleins by members of the Polo-like kinase family.
@en
Phosphorylation of synucleins by members of the Polo-like kinase family.
@nl
P2093
P2860
P50
P356
P1476
Phosphorylation of synucleins by members of the Polo-like kinase family.
@en
P2093
Abid Oueslati
Ahmed Boucharaba
Diana Olschewski
Guowei Yin
Harald Hirling
Heinrich Schell
Katerina E Paleologou
Margot Fournier
Martial K Mbefo
Philipp J Kahle
P2860
P304
P356
10.1074/JBC.M109.081950
P407
P577
2009-11-04T00:00:00Z